-
capabilities of single cell platforms. Analyze and communicate results and data analysis from high throughput sequencing platforms. Share responsibility with other lab members for lab maintenance, including
-
of Dr. Amanda Wasylishen at the University of Cincinnati College of Medicine, in the Department of Cancer Biology, to study cell state regulation in the pancreas and pancreatic cancer development
-
liquid-liquid phase separation (LLPS) and the above processes [Estrogen Receptor and Breast Cancer – Celebrating the 60th Anniversary of the Discovery of ER (1st ed, 2019, Springer Nature), Cell Reports
-
renal cancer, clear cell renal cell carcinoma (ccRCC). Research integrates state-of-the-art molecular biology using cell-based and animal models as well as system biology bioinformatics multiomics
-
renal cancer, clear cell renal cell carcinoma (ccRCC). Research integrates state-of-the-art molecular biology using cell-based and animal models as well as system biology bioinformatics multiomics
-
. The initial appointment is for one year, with possible annual renewals for another two years based on performance. The start date is immediately but is flexible between July 2024 and October 2024. Essential
-
blood flow is restored. Repair injured heart through developing new cell-based therapy approaches. Responsible for stem cell isolation, culture, expansion, and induction with various bioactive molecules
-
a strong background in cell biology, molecular biology, biomedical engineering, genome editing, recombinant vector construction, induced pluripotent stem cell (iPSC) culture and differentiation, and
-
including RT-PCR, Western Blot, and immunostaining for histological analyses for at least 1 year. Applicant should have experience in molecular biology, cell-based technologies including cell culture and
-
experiment such as cell culture (maintenance and test on cancer cells or organoids), molecular biology (DNA/RNA extraction, PCR, cloning, biochemical assays and, western blot) and in-vivo experiments such as